Pliant Therapeutics Insider Trades
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 4 · $163.62K
- Shares bought / sold
- 0 / 127.83K
- Net activity
- Net selling $163,620
Pliant Therapeutics insider activity
Over the last 12 months, Pliant Therapeutics insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 4 sales. Insiders bought $0 and sold $163,620 worth of stock, for net insider selling of $163,620. The largest seller was Coulie Bernard, with $114,400 in reported sales.
The most recent filing shows Coulie Bernard (President and CEO) selling 89,375 shares at $1.28 on Jan 20, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLRX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PLRX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 20, 2026 | Kuo MinnieChief Operating Officer | Sale | 6,917 | $8.85K | Form 4 |
| Jan 20, 2026 | Cheung LilyChief Human Resource Officer | Sale | 7,534 | $9.64K | Form 4 |
| Jan 20, 2026 | Cummings Keith LamontChief Financial Officer | Sale | 24,002 | $30.72K | Form 4 |
| Jan 20, 2026 | Coulie BernardPresident and CEO | Sale | 89,375 | $114.40K | Form 4 |
| Jan 23, 2025 | Lefebvre EricChief Medical Officer | Award | 45,650 | — | Form 4 |
| Jan 23, 2025 | Ouimette MikeGeneral Counsel & Corp. Sec'y | Award | 35,000 | — | Form 4 |
| Jan 23, 2025 | Hull HansChief Business Officer | Award | 40,150 | — | Form 4 |
| Jan 23, 2025 | Coulie BernardPresident and CEO | Award | 162,500 | — | Form 4 |
| Jan 23, 2025 | Cummings Keith LamontChief Financial Officer | Award | 56,650 | — | Form 4 |
| Jan 23, 2025 | Cheung LilyChief Human Resource Officer | Award | 25,875 | — | Form 4 |
| Jan 17, 2025 | Lefebvre EricChief Medical Officer | Sale | 18,478 | $206.97K | Form 4 |
| Jan 17, 2025 | Hull HansChief Business Officer | Sale | 15,936 | $178.50K | Form 4 |
| Jan 17, 2025 | Cummings Keith LamontChief Financial Officer | Sale | 20,148 | $225.68K | Form 4 |
| Jan 17, 2025 | Coulie BernardPresident and CEO | Sale | 52,419 | $587.15K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4